
The rate of HIV-associated dementia is so high in sub-Saharan Africa that it has become one of the most common types of dementia in the world, according to an international study led by Johns Hopkins Medical Institution. Alzheimer’s and strokes are the other most frequent causes.
HIV dementia encompasses memory, learning, behavioral, and motor disabilities that interfere with normal daily life. In extreme cases, it can lead to total disability.
In the study, published in the current issue of Neurology, researchers found 31% of a small but representative group of 178 HIV-positive patients in Uganda were found to have HIV dementia.
"Clearly, large-scale testing would have to be conducted before we know the global reach of HIV dementia, but this study sends a clear message that it exists in high proportions in sub-Saharan Africa and is an underrecognized condition that needs to be studied and treated," said Ned Sacktor, a Johns Hopkins neurologist and senior author of the multi-institutional study.
Fortunately, HIV dementia, unlike the Alzheimer’s- and stroke-induced varieties, is treatable with antiretroviral medication. Treatment can restore completely normal cognitive function to some of those affected.
Dementia disrupts jobs, adds to the cost of health care, and also interferes with a patient’s ability to adhere to a regular course of antiretroviral medication, thus increasing the risk of drug resistance. People with dementia also are less likely to practice safe sex.
An estimated 27 million adults and children are HIV-positive in the sub-Saharan Africa. "If the rate we saw in our study translates across sub-Saharan Africa, we’re looking at more than 8 million people in this region with HIV dementia," said Sacktor.
These comments are reproduced as written by visitors to this Web site. They have not been edited for content, grammar, or spelling. The viewpoints appearing here are those of the writer, and do not necessarily reflect the opinion or views of advocate.com, The Advocate, or its affiliates.
Be the first to comment on this story.
If you would like to submit a comment for posting, please fill out the form above.
All comments submitted via this form are subject to posting or publication. (To send a private letter to an Advocate editor or writer, please use the e-mail button at the top of the page, or use snail mail.) If you would like your comment considered for publication in The Advocate magazine, please include your full name, your city of residence, and a phone number where you can be reached during business hours so that we can confirm your identity. Your e-mail address and telephone number are strictly confidential and will not be shared or used for any purpose other than to contact you about your comment.
Comments that do not concern specific articles in The Advocate or on Advocate.com will not be posted or published. See the Contact page for sending comments for reasons other than responding to Advocate editorial and news stories.
Please note that comments sent by fax or snail mail are unlikely to be posted, although they will be considered for publication along with all letters received via e-mail or via this Web page. Comments that chiefly concern Advocate.com content will be considered for posting only on the Web site. The Advocate reserves the right to edit submitted comments for grammar, spelling, obscenities, or libel; we will, however, do our best to preserve the original comment's style and intent. Comments considered for publication in The Advocate magazine may also be edited for length.